Monitoring of l-arginine and endogenous dimethylarginines in survivor septic patients-a pilot study

Balázs Németh, István Kiss, Iván Péter, Zénó Ajtay, Ádám Németh, L. Márk, Attila Csorba, Tamás Kszegi, Diána Mühl, Péter Kustán

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Background/Aim: Nitric oxide (NO) pathway plays a major role in the development and advancement of inflammation. We aimed to design a study and investigate its feasibility to show the changes of L-arginine, asymmetric dimethylarginine (ADMA) and symmetric dimethylarginine (SDMA), which are important regulators of the NO pathway. Patients and Methods: Concentrations of L-arginine, ADMA and SDMA were measured by liquid chromatographytandem mass spectrometry. Seventeen septic survival patients were enrolled and blood samples were obtained on the first, third and fifth day after the diagnosis of sepsis. Sixteen nonseptic matched controls were recruited. Results: ADMA levels on admission correlated well with sequential organ failure assessment (SOFA) score. During the follow-up, Larginine/ ADMA ratio increased significantly from day 1 to day 3 (p=0.005), then decreased from day 3 to day 5 (p=0.023). Conclusion: This study design seems feasible to investigate changes of L-Arginine, ADMA and SDMA in sepsis survival patients.

Original languageEnglish
Pages (from-to)663-669
Number of pages7
JournalIn Vivo
Volume30
Issue number5
Publication statusPublished - Sep 1 2016

Fingerprint

Survivors
Arginine
Monitoring
Sepsis
Nitric Oxide
Organ Dysfunction Scores
Survival
Mass spectrometry
Mass Spectrometry
Blood
N,N-dimethylarginine
dimethylarginine
Inflammation
Liquids
N,N'-dimethylarginine

Keywords

  • Asymmetric dimethylarginine
  • L-arginine
  • Nitric oxide
  • Sepsis
  • Survival

ASJC Scopus subject areas

  • Medicine(all)
  • Biochemistry, Genetics and Molecular Biology(all)
  • Pharmacology

Cite this

Németh, B., Kiss, I., Péter, I., Ajtay, Z., Németh, Á., Márk, L., ... Kustán, P. (2016). Monitoring of l-arginine and endogenous dimethylarginines in survivor septic patients-a pilot study. In Vivo, 30(5), 663-669.

Monitoring of l-arginine and endogenous dimethylarginines in survivor septic patients-a pilot study. / Németh, Balázs; Kiss, István; Péter, Iván; Ajtay, Zénó; Németh, Ádám; Márk, L.; Csorba, Attila; Kszegi, Tamás; Mühl, Diána; Kustán, Péter.

In: In Vivo, Vol. 30, No. 5, 01.09.2016, p. 663-669.

Research output: Contribution to journalArticle

Németh, B, Kiss, I, Péter, I, Ajtay, Z, Németh, Á, Márk, L, Csorba, A, Kszegi, T, Mühl, D & Kustán, P 2016, 'Monitoring of l-arginine and endogenous dimethylarginines in survivor septic patients-a pilot study', In Vivo, vol. 30, no. 5, pp. 663-669.
Németh B, Kiss I, Péter I, Ajtay Z, Németh Á, Márk L et al. Monitoring of l-arginine and endogenous dimethylarginines in survivor septic patients-a pilot study. In Vivo. 2016 Sep 1;30(5):663-669.
Németh, Balázs ; Kiss, István ; Péter, Iván ; Ajtay, Zénó ; Németh, Ádám ; Márk, L. ; Csorba, Attila ; Kszegi, Tamás ; Mühl, Diána ; Kustán, Péter. / Monitoring of l-arginine and endogenous dimethylarginines in survivor septic patients-a pilot study. In: In Vivo. 2016 ; Vol. 30, No. 5. pp. 663-669.
@article{a7b34e9b5d55462eaf24cf9606813986,
title = "Monitoring of l-arginine and endogenous dimethylarginines in survivor septic patients-a pilot study",
abstract = "Background/Aim: Nitric oxide (NO) pathway plays a major role in the development and advancement of inflammation. We aimed to design a study and investigate its feasibility to show the changes of L-arginine, asymmetric dimethylarginine (ADMA) and symmetric dimethylarginine (SDMA), which are important regulators of the NO pathway. Patients and Methods: Concentrations of L-arginine, ADMA and SDMA were measured by liquid chromatographytandem mass spectrometry. Seventeen septic survival patients were enrolled and blood samples were obtained on the first, third and fifth day after the diagnosis of sepsis. Sixteen nonseptic matched controls were recruited. Results: ADMA levels on admission correlated well with sequential organ failure assessment (SOFA) score. During the follow-up, Larginine/ ADMA ratio increased significantly from day 1 to day 3 (p=0.005), then decreased from day 3 to day 5 (p=0.023). Conclusion: This study design seems feasible to investigate changes of L-Arginine, ADMA and SDMA in sepsis survival patients.",
keywords = "Asymmetric dimethylarginine, L-arginine, Nitric oxide, Sepsis, Survival",
author = "Bal{\'a}zs N{\'e}meth and Istv{\'a}n Kiss and Iv{\'a}n P{\'e}ter and Z{\'e}n{\'o} Ajtay and {\'A}d{\'a}m N{\'e}meth and L. M{\'a}rk and Attila Csorba and Tam{\'a}s Kszegi and Di{\'a}na M{\"u}hl and P{\'e}ter Kust{\'a}n",
year = "2016",
month = "9",
day = "1",
language = "English",
volume = "30",
pages = "663--669",
journal = "In Vivo",
issn = "0258-851X",
publisher = "International Institute of Anticancer Research",
number = "5",

}

TY - JOUR

T1 - Monitoring of l-arginine and endogenous dimethylarginines in survivor septic patients-a pilot study

AU - Németh, Balázs

AU - Kiss, István

AU - Péter, Iván

AU - Ajtay, Zénó

AU - Németh, Ádám

AU - Márk, L.

AU - Csorba, Attila

AU - Kszegi, Tamás

AU - Mühl, Diána

AU - Kustán, Péter

PY - 2016/9/1

Y1 - 2016/9/1

N2 - Background/Aim: Nitric oxide (NO) pathway plays a major role in the development and advancement of inflammation. We aimed to design a study and investigate its feasibility to show the changes of L-arginine, asymmetric dimethylarginine (ADMA) and symmetric dimethylarginine (SDMA), which are important regulators of the NO pathway. Patients and Methods: Concentrations of L-arginine, ADMA and SDMA were measured by liquid chromatographytandem mass spectrometry. Seventeen septic survival patients were enrolled and blood samples were obtained on the first, third and fifth day after the diagnosis of sepsis. Sixteen nonseptic matched controls were recruited. Results: ADMA levels on admission correlated well with sequential organ failure assessment (SOFA) score. During the follow-up, Larginine/ ADMA ratio increased significantly from day 1 to day 3 (p=0.005), then decreased from day 3 to day 5 (p=0.023). Conclusion: This study design seems feasible to investigate changes of L-Arginine, ADMA and SDMA in sepsis survival patients.

AB - Background/Aim: Nitric oxide (NO) pathway plays a major role in the development and advancement of inflammation. We aimed to design a study and investigate its feasibility to show the changes of L-arginine, asymmetric dimethylarginine (ADMA) and symmetric dimethylarginine (SDMA), which are important regulators of the NO pathway. Patients and Methods: Concentrations of L-arginine, ADMA and SDMA were measured by liquid chromatographytandem mass spectrometry. Seventeen septic survival patients were enrolled and blood samples were obtained on the first, third and fifth day after the diagnosis of sepsis. Sixteen nonseptic matched controls were recruited. Results: ADMA levels on admission correlated well with sequential organ failure assessment (SOFA) score. During the follow-up, Larginine/ ADMA ratio increased significantly from day 1 to day 3 (p=0.005), then decreased from day 3 to day 5 (p=0.023). Conclusion: This study design seems feasible to investigate changes of L-Arginine, ADMA and SDMA in sepsis survival patients.

KW - Asymmetric dimethylarginine

KW - L-arginine

KW - Nitric oxide

KW - Sepsis

KW - Survival

UR - http://www.scopus.com/inward/record.url?scp=84992029488&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84992029488&partnerID=8YFLogxK

M3 - Article

VL - 30

SP - 663

EP - 669

JO - In Vivo

JF - In Vivo

SN - 0258-851X

IS - 5

ER -